• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 37 of 100
Second wave coronavirus
Newsletters
A second coronavirus wave isn’t imminent—the first one never ended
By Sy MukherjeeJune 11, 2020
AstraZeneca Gilead deal
Health
Rumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By Sy MukherjeeJune 8, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health
5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
Finance
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
Hydroxychloroquine study shows deaths, heart risks in COVID-19 patients
Health
Hydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By John Lauerman and BloombergMay 22, 2020
Moderna Therapeutics coronavirus vaccine
Newsletters
Moderna’s coronavirus vaccine expectations game
By Sy MukherjeeMay 21, 2020
Tobacco giants are getting into the coronavirus vaccine race
Health
Tobacco giants are getting into the coronavirus vaccine race
By Sy MukherjeeMay 21, 2020
Moderna coronavirus vaccine trial
Health
Moderna releases promising—but early—new coronavirus vaccine data
By Sy MukherjeeMay 18, 2020
ZOE.07.20.Kristin-Peck
Magazine
The CEO who keeps animal pharm growing
By Anne SradersMay 16, 2020
Antibody testing will be key—once we understand what the results mean
Health
Antibody testing will be key—once we understand what the results mean
By Sy MukherjeeMay 12, 2020
Gilead remdesivir price
Newsletters
Gilead’s moral (and financial) COVID-19 conundrum
By Sy MukherjeeMay 7, 2020
Gilead-Sciences-Remdesivir
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By Sy MukherjeeMay 1, 2020
COVID forgotten communities
Newsletters
The communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
Health
Gilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
Health
The coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
1...
  • 35
  • 36
  • 37
  • 38
  • 39
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.